Influence of the Time Interval until the Start of adjuvant Chemotherapy on Overall Survival in Patients with triple-negative Breast Cancer

被引:0
|
作者
Hatzipanagiotou, M. E. [1 ]
Pigerl, M. C. [1 ]
Gerken, M. [2 ,3 ]
Raepple, S. [1 ]
Zeltner, V [1 ]
Ugocsai, P. [1 ]
Ortmann, O. [1 ]
Klinkhammer-Schalke, M. [2 ,3 ]
Seitz, S. [1 ]
机构
[1] Lehrstuhl Univ Regensburg, Caritas Krankenhaus St Josef, Klin Frauenheilkunde & Geburtshilfe, Regensburg, Germany
[2] Univ Regensburg, Inst Qual Management & Hlth Serv Res, Tumor Ctr, Regensburg, Germany
[3] Bavarian Hlth & Food Safety Author, Reg Ctr Regensburg, Bavarian Canc Registry, Regensburg, Germany
关键词
D O I
10.1055/s-0043-1768845
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
P49
引用
收藏
页码:739 / 740
页数:2
相关论文
共 50 条
  • [1] Association of Adjuvant Chemotherapy With Overall Survival Among Women With Small, Node-Negative, Triple-Negative Breast Cancer
    Oladeru, Oluwadamilola T.
    Singh, Anurag K.
    Ma, Sung Jun
    JAMA NETWORK OPEN, 2020, 3 (09)
  • [2] Dose dense neoadjuvant and adjuvant chemotherapy in triple-negative breast cancer patients: Survival analysis
    Kr, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [3] Adjuvant Chemotherapy in early stage Triple-Negative Breast Cancer Patients
    Pfeiler, G.
    Koenigsbergt, R.
    Natter, C.
    Jahn-Kuch, D.
    Hudec, M.
    Zeilinger, R.
    Dittrich, C.
    Singer, C.
    ONKOLOGIE, 2010, 33 : 26 - 26
  • [4] Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer
    Guo, Qiusheng
    Lan, Tian
    Lu, Yunyan
    Hu, Zujian
    Xu, Haibin
    Wang, Xiaojia
    Shao, Xiying
    Fu, Xueyan
    BIOMOLECULES AND BIOMEDICINE, 2023, 23 (03): : 502 - 509
  • [5] Extended Adjuvant Chemotherapy in Triple-Negative Breast Cancer
    Locatelli, Marzia A.
    Curigliano, Giuseppe
    Eniu, Alexandru
    BREAST CARE, 2017, 12 (03) : 152 - 158
  • [6] Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?
    Pomponio, Maria K.
    Keele, Luke J.
    Fox, Kevin R.
    Clark, Amy S.
    Matro, Jennifer M.
    Shulman, Lawrence N.
    Tchou, Julia C.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 177 (01) : 137 - 143
  • [7] Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?
    Maria K. Pomponio
    Luke J. Keele
    Kevin R. Fox
    Amy S. Clark
    Jennifer M. Matro
    Lawrence N. Shulman
    Julia C. Tchou
    Breast Cancer Research and Treatment, 2019, 177 : 137 - 143
  • [8] Post-adjuvant chemotherapy for triple-negative breast cancer
    Sun, Shanping
    Zhao, Yijun
    Xu, Kun
    MEDICAL HYPOTHESES, 2016, 90 : 74 - 75
  • [9] Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer
    Stover, Daniel G.
    Bell, Caitlin F.
    Tolaney, Sara M.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 6 - 12
  • [10] Effect of treatment interruptions on overall survival in patients with triple-negative breast cancer
    Chow, Ronald
    Hasan, Shaakir
    Choi, J. Isabelle
    Fox, Jana
    Chhabra, Arpit M.
    Marshall, Deborah C.
    Bakst, Richard L.
    Simone II, Charles B.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (09): : 1029 - 1035